Functional expression of MDR-1 in acute myeloid leukemia: Correlation with the clinical-biological, immunophenotypical, and prognostic disease characteristics

Annals of Hematology

Volumn 75, Issue 3, 1997, Pages 81-86

  Martinez A ^a   San Miguel, J F ^a   Valverde, B ^b   Barez A ^c   Moro, M J ^d   Garcia Marcos M A ^a   Perez Simon J A ^a   Vidriales, B ^a   Orfao, A ^e  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b National Children's Hospital   (Costa Rica)

^c Social Security Hospital   (Spain)

^d Virgen Blanca   (Spain)

^e UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Acute myeloid leukemia; Flow cytometry; Multidrug resistance; P glycoprotein; Prognostic factors

Indexed keywords

GLYCOPROTEIN P; HLA DR ANTIGEN; RHODAMINE 123; STEM CELL FACTOR RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANTIGEN EXPRESSION; ARTICLE; BLAST CELL; CANCER GROWTH; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL TIME; THROMBOCYTE COUNT;

ADULT; AGED; COLORING AGENTS; FLUORESCENT DYES; GENE EXPRESSION; GENES, MDR; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, MYELOID; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RHODAMINE 123; RHODAMINES;

EID: 0030667219     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050318     Document Type: Article

References (41)

1. Campos L, Guyotat D, Archimbaud E, Calmard-Oriol P, Tsuruo T, Troncy J, Treille D, Fiere D (1992) Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood 79:473-476
2. Campos L, Guyotat D, Jaffar C, Solary E, Archimbaud E, Treille D (1992) Correlation of MDR1/P-170 expression with daunorubicin uptake and sensitivity of leukemic progenitors in acute myeloid leukemia. Eur J Haematol 48:254-258
3. Chaudhary PM. Roninson IB (1991) Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66:85-94
4. Cheson BD, Cassileth PA, Head DR, Schiffer CA, Bennett JM, Bloomfield CD, Brunning R, Gale RP, Grever MR, Keating MJ, et al (1990) Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 8:813-819
5. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650-1654
6. D'Arpa P, Liu LF (1989) Topoisomerase-targeting antitumor drugs. Biochim Biophys Acta 989:163-177
7. Del Poeta G, Stasi R, Venditti A, Suppo G, Aronica G, Bruno A, Masi M, Tabilio A, Papa G (1994) Prognostic value of cell marker analysis in de novo acute myeloid leukemia. Leukemia 8:388-394
8. Dixon WJ (1993) Biomedical data package: statistical software. University of California, Berkeley, Calif.
9. Fox M, Roberts JJ (1987) Drug resistance and DNA repair. Cancer Metastasis Rev 6:261-281
10. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM, et al (1989) Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81:116-124
11. Gsur A, Zochbauer S, Gotzl M, Kyrle PA, Lechner K, Pirker R (1993) MDR1 RNA expression as a prognostic factor in acute myeloid leukemia: an update. Leuk Lymphoma 12:91-94
12. Guerci A, Merlin JL, Missoum N, Feldmann L, Marchai S, Witz F, Rose C, Guerci O (1995) Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry. Blood 85:2147-2153
13. Harris AL, Hochhauser D (1992) Mechanisms of multidrug resistance in cancer treatment. Acta Oncol 31:205-213
14. Hart SM, Ganeshaguru K, Lyttelton MP, Prentice HG, Hoffbrand AV, Mehta AB (1993) Flow cytometric assessment of multidrug resistance (MDR) phenotype in acute myeloid leukaemia. Leuk Lymphoma 11:239-248
15. Ino T, Miyazaki H, Isogai M, Nomura T, Tsuzuki M, Tsuruo T, Ezaki K, Hirano M (1994) Expression of P-glycoprotein in de novo acute myelogenous leukemia at initial diagnosis: results of molecular and functional assays, and correlation with treatment outcome. Leukemia 8:1492-1497
16. Kaye SB (1995) Clinical drug resistance: the role of factors other than P-glycoprotein. Am J Med 99:40S-44S
17. Kuss BJ, Deeley RG, Cole SP, Willman CL, Kopecky KJ, Wolman SR, Eyre HJ, Lane SA, Nancarrow JK, Whitmore SA, et al (1994) Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications. Lancet 343:1531-1534
18. Kuwazuru Y, Yoshimura A, Hanada S, Utsunomiya A, Makino T, Ishibashi K, Kodama M, Iwahashi M, Arima T, Akiyama S (1990) Expression of the multidrug transporter, P-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance. Cancer 66:868-873
19. Lamy T, Goasguen JE, Mordelet E, Grulois I, Dauriac C, Drenou B, Chaperon J, Fauchet R, le Prise PY (1994) P-glycoprotein (P-170) and CD34 expression in adult acute myeloid leukemia (AML). Leukemia 8:1879-1883
20. Lamy T, Drenou B, Grulois I, Fardel O, Jacquelinet C, Goasguen J, Dauriac C, Amiot L, Bernard M, Fauchet R, et al (1995) Multi-drug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay. Leukemia 9:1549-1555
21. Leith CP, Chen IM, Kopecky KJ, Appelbaum FR, Head DR, Godwin JE, Weick JK, Willman CL (1995) Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux + and MDR1 +/efflux- cases. Blood 86:2329-2342
22. List AF, Spier CM, Cline A, Doll DC, Garewal H, Morgan R, Sandberg AA (1991) Expression of the multidrug resistance gene product (P-glycoprotein) in myelodysplasia is associated with a stem cell phenotype. Br J Haematol 78:28-34
23. Ludescher C, Thaler J, Drach D, Drach J, Spitaler M, Gattringer C, Huber H, Hofmann J (1992) Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123. Br J Haematol 82:161-168
24. Ludescher C, Eisterer W, Hilbe W, Gotwald M, Hofmann J, Zabernigg A, Cianfriglia M, Thaler J (1995) Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia. Leukemia 9:350-356
25. Orfao A, Ciudad J, Lopez-Berges MC, Lopez A, Vidriales B, Caballero MD, Valverde B, Gonzalez M, San Miguel JF (1994) Acute lymphoblastic leukemia (ALL): detection of minimal residual disease (MRD) at flow cytometry. Leuk Lymphoma 13 [Suppl 1]:87-90
26. Paietta E, Andersen J, Racevskis J, Gallagher R, Bennett J, Yunis J, Cassileth P, Wiernik PH (1994) Significantly lower P-glycoprotein expression in acute promyelocytic leukemia than in other types of acute myeloid leukemia: immunological. molecular and functional analyses. Leukemia 8:968-973
27. Pinedo HM, Giaccone G (1995) P-glycoprotein - a marker of cancer-cell behavior. N Engl J Med 333:1417-1419
28. Pirker R, Wallner J, Geissler K, Linkesch W, Haas OA, Bettelheim P, Hopfner M, Scherrer R, Valent P, Havelec L, et al (1991) MDR1 gene expression and treatment outcome in acute myeloid leukemia. J Natl Cancer Inst 83:708-712
29. Reed JC (1995) Bcl-2: prevention of apoptosis as a mechanism of drug resistance. Hematol Oncol Clin North Am 9:451-473
30. Ross DD, Wooten PJ, Sridhara R, Ordoñez JV, Lee EJ, Schiffer CA (1993) Enhancement of daunorubicin accumulation, retention, and cytotoxicity by verapamil or cyclosporin-A in blast cells from patients with previously untreated acute myeloid leukemia. Blood 82:1288-1299
31. San Miguel JF, van Dongen JJ (1997) Methods for detection of minimal residual disease. In: Büchner T, Hiddemann W, Wörman B, Schelleng G, Ritter J, Creutzig V (eds) Acute leukemias VI, prognosis factors and treatment strategies. Springer-Verlag, Berlin Heidelberg New York
32. Sato H, Preisler H, Day R, Raza A, Larson R, Browman G, Goldberg J, Vogler R, Grunwald H, Gottlieb A, et al (1990) MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia. Br J Haematol 75:340-345
33. Scheffer GL, Wijngaard PL, Flens MJ, Izquierdo MA, Slovak ML, Pinedo HM, Meijer CJ, Clevere HC, Scheper RJ (1995) The drug resistance-related protein LRP is the human major vault protein. Nat Med 1:578-582
34. Schlaifer D, Laurent G, Chittal S, Tsuruo T, Soues S, Muller C, Charcosset JY, Alard C, Brousset P, Mazerrolles C, et al (1990) Immunohistochemical detection of multidrug resistance associated P-glycoprotein in tumour and stromal cells of human cancers. Br J Cancer 62:177-182
35. Stasi R, Del Poeta G, Venditti A, Masi M, Stipa E, Dentamaro T, Cox C, Dallapiccola B, Papa G (1994) Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0). Blood 83:1619-1625
36. te Boekhorst PA, de Leeuw K, Schoester M, Wittebol S, Nooter K, Hagemeijer A, Lowenberg B, Sonneveld P (1993) Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells. Blood 82:3157-3162
37. te Boekhorst PA, Lowenberg B, van Kapel J, Nooter K, Sonneveld P (1995) Multidrug resistant cells with high proliferative capacity determine response to therapy in acute myeloid leukemia. Leukemia 9:1025-1031
38. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC (1989) Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and cross-reactivity of one antibody with a muscle protein. J Histochem Cytochem 37:159-164
39. van Dongen JJ, Breit TM, Adriaansen HJ, Beishuizen A, Hooijkaas H (1992) Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction. Leukemia 6 [Suppl 1]:47-59
40. Zhou DC, Hoang-Ngoc L, Delmer A, Faussat AM, Russo D, Zittoun R, Marie JP (1994) Expression of resistance genes in acute leukemia. Leuk Lymphoma 13 [Suppl 1]:27-30
41. Zochbauer S, Gsur A, Brunner R, Kyrie PA, Lechner K, Pirker R (1994) P-glycoprotein expression as unfavorable prognostic factor in acute myeloid leukemia. Leukemia 8:974-977